SearchDictionaryMobileLogin

Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.

AuthorsM Benucci, Gobbi F Li, A Del Rosso, M Manfredi
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2005 Sep-Oct Vol. 23 Issue 5 Pg. 733 ISSN: 0392-856X Italy
PMID16173267 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • adalimumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Still's Disease, Adult-Onset (drug therapy)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)